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Abstract
Background: Our previous research showed that icariin (1) and its phosphorylated structural modification (2) improved
the survival and attenuated oxidative stress and liver dysfunction induced by duck virus hepatitis. In this paper, we were
one step closer to determine the structure of phosphorylation icariin (2) by the FT-IR, HRESIMS and 13C NMR. Anti-DHAV
activities of 1 and 2 were compared in duck embryonic hepatocytes (DEHs) cultured in vitro and by artificial infection
method in vivo. Additionally, the antiviral mechanisms of replication/release in vitro and the DHAV gene expression in vivo
of 1 and 2 were analyzed.
Results: Compound 2's molecular formula was C33H42O18P. The results indicated that 1 and 2 effectively resisted DHAV
invading DEHs, that they decreased the mortality of ducklings challenged with DHAV, and that 2 performed more
effectively. 1 and 2 performed evenly on DHAV release; however, 2 restrained virus replication far more effectively.
Since the anti-DHAV mechanisms of 1 and 2 in vitro probably involve suppression of replication and release, 2’s better
performance in anti-DHAV may result from its far more effectively inhibiting virus replication.
Conclusions: The compound 2's chemical structure was defined as 8-prenylkaempferol-4'-methylether-3-rhamnosyl-7-
(6'''-phosphate)-glycoside. 1 and 2 exhibited anti-virus activity on DHAV. Our results suggest that 1 and 2 might become
an anti-virus plant material candidate.
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Background
Duck viral hepatitis (DVH) is an acute, contagious,
highly fatal disease of young ducklings, which was first
described on Long Island, NY, USA, in 1949 [1]. The
causative agent, duck hepatitis virus (DHV), historically
belongs to the family Picornaviridae and is divided into
three serotypes (DHV-1, 2, and 3). DHV-1 is the most
widely distributed and the most virulent one among the
three types of DHV [2]. Recently, sequence analysis of
duck hepatitis virus type 1 led to its classification as the
only member of a new genus, Avihepatovirus, of the
family Picornaviridae, so the DHV-1 was renamed to
DHAV [3]. DHAV predominantly infects young duck-
lings aged less than three weeks. Clinically, the disease is
acute, rapidly spreading, with a shorter course and high
mortality rate. Meanwhile, the DVH is an attractive re-
search model of human hepatitis, with great potential-
ities in both human and veterinary medicine [4]. In the
absence of effective anti-DHAV drugs, immunizing
ducks or young ducklings with attenuated DHAV vac-
cines is the primary approach to disease control. How-
ever, vaccines are not totally effective and any clinical
manifestation may cause potentially irreparable damage.
Several types of flavonoids including those from epi-
medium and propolis as well as prescriptions of flavonoids
ingredients showed significant resistance to Newcastle dis-
ease, infectious bursal disease and other viral diseases in
our previous experiments [5], although the underlying
mechanisms were not researched in detail. Epimedium is
a well-known traditional herbal medicine in China used
for centuries to invigorate kidney and strengthen kidney –
yang. Contemporary pharmacologic experiments indicate
that Epimedium flavone has anti-aging, anti-tumor and
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anti-osteoporosis activities [6–9]. Icariin (C33H40O15, 1,
Fig. 1.) is the main effective component of Epimedium bre-
vicornum Maxim [10]. 1 exhibits many biological activities
and pharmacological effects, including antioxidant, anti-
inflammatory, anti-tumor [11]. Previous research showed
that 1 enhanced the cellular and humoral immunity in
mice, and increased the phagocytic activity of macrophages
in immune-depression mouse models caused by massive
doses of hydrocortisone and hydroxycarbamide [12]. There-
fore, we choose the 1 as the study object.
Molecular modification of flavonoids and polysacchar-
ide became an important research field along with the
increasing pursuit about manifold biological activities of
modified. Many studies confirmed that the biological
activities of the Chinese herbal ingredients could be im-
proved by the chemical method (sulfated, phosphated,
selenylation). In our previous published work, we found that
the compound 1 and phosphorylated icariin (C33H42O18P,
2, Fig. 1) could alleviate the oxidative stress and liver injury
in ducklings caused by DHAV. These outcomes were better
in ducklings treated with 2 than in those treated by 1. In
clinical trials, compared with 1, 2 could significantly im-
prove survival rate [13]. This is the most important to the
meaning of the actual production application. So we believe
that this novel structure resulted in the difference. But
between the 1 and 2, their antioxidant effect was similar. It’s
suggested that there may be another resistance mechanisms
to anti-DHAV infection. To further study its resistance
mechanism, we hold the opinion that it is essential to con-
firm the structure of 2 and study the effect of drug for viral
multiplication process. Above on, we determined the chem-
ical structure of 2 by the FT-IR, HRESIMS and 13C NMR
and the compound 1 and compound 2 antiviral efficacies
against DHAV in vivo and in vitro were investigated.
Methods
Reagents and virus
Dulbecco’s modified eagle medium (DMEM) (Gibco)
supplemented with streptomycin 100 IU/mL, penicillin
100 IU/mL, 10% fetal bovine serum and glutamine
0.75 mg/mL was used as the nutritive medium. The fetal
bovine concentration of the maintain medium (MM)
was reduced to 1 %. Dulbecco’s Hanks Balanced Salt So-
lution (D-Hank’s) was used for washing the embryo. The
pH of D-Hank’s, DMEM and MM solutions was ad-
justed to 7.4 with 5.6 % NaHCO3 and stored at 4 °C.
Trypsin (Amresco) was dissolved with D-Hank’s up to
0.2 %. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium bromide (MTT, Amresco) was dissolved to 5 mg/
mL with phosphate-buffered saline (PBS), filtered through a
0.22 μm syringe filter, and stored at 4 °C in dark bottles.
Other chemicals used in the experiment were analytical
grade. RNAiso Plus Reagent (Lot no. 9108), PrimeScript RT
Master Mix Kit (Lot no. RR036A) and SYBR Premix Ex
Taq (Tli RNaseH Plus) Kit (Lot no. RR036A) were bought
from Takara. Fluorescein isothiocyanate-labeled rabbit anti-
DHAV (Lot no. orb8860) was bought from biorbyt. DHAV
(LD50:5 × 10
−3) strain LQ2 used in the challenge experi-
ments was supplied by the Shandong Institute of Poultry
(Shandong, China,−70 °C storage). All other chemicals
are from standard commercial suppliers, having analyt-
ical grade quality.
Preparation of icariin
Compound 1 was purified repeatedly from the extract of
Epimedium segittatum by column chromatography (CC)
and prepared HPLC. The dried leaves (5 kg) of this plant
were extracted three times with 85 % (v/v) EtOH under
refluxed (40 L each time for 2 h). The combined extract
was concentrated under reduced pressure to give a resi-
due (0.3 kg), which was further partitioned with petrol-
eum ether (PE, boiling point 60–90 °C, 4 L), ethyl
acetate (EtOAc, 4 L) and n-BuOH (4 L), successively.
The EtOAc fraction (38 g) was subjected to a silica gel
CC (400 g, 100–200 mesh, 600 × 40 mm) eluted with a
step gradient of CH2Cl2-MeOH-H2O (90:1:0.1, 40:1:0.1,
20:1:0.1, 10:1:0.1, 5:1:0.1, v/v, 3 L each step gradient) to
give five sub-fractions (E1-E5, 2.2 g, 3.1 g, 3.8 g, 4.6 g,
8.9 g, respectively). E4 (0.2 g) was then purified by
Sephadex LH-20 CC (1200 × 24 mm) with MeOH-H2O
(2:1 to 1:1, v/v, 1.2 L each gradient) to obtain crude flavo-
noids (0.12 g). The crude flavonoids were further sepa-
rated by prepared HPLC (column Kromasil 250 × 10 mm,
5 μm, CH3CN-H2O, 23:77, v/v, 1.6 L) and recrystallized
Fig. 1 Structure of icariin (1) and 6'''-phosphate icariin (2)
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with water repeatedly to yield Icariin (83 mg), whose pur-
ity quotient was over 98 %.
HPLC conditions: YMC-Triart C18, (5 μm, 4.6 × 250 mm;
YMC), solvent system: A - MeOH, B-H2O, C - MeCN, D -
0.2 % H3PO4; flow rate: 1 mL/min; injection volume: 20 μL;
Sample concentration: 10 mg/mL in MeOH. DAD condi-
tions: 270 nm.
HRESIMS conditions: positive ion mode; scan range:
500–4000m/z; source temperature: 300 °C; ion spray volt-
age 4 kV.
Preparation of phosphorylated icariin
2.5 g sodium trimetaphosphate and 1.0 g sodium tripoly-
phosphate were mixed in 50 mL of distilled water, with stir-
ring. Compound 1 (500 mg) was dissolved in 100 mL of
distilled water and added to the sodium trimetaphosphate-
sodium tripolyphosphate reagent, and stirred in a water
bath at 70 °C for 6 h at pH 9. The resulting solution was
dialyzed, purified by ODS column chromatography and
preparative HPLC (YMC, 4 μm, 150 mm× 20 mm, MeCN/
H2O, 35: 65), UV detection at 210 nm, and lyophilized to
yield compound 2.
Icariin (1): yellow amorphous powder; FT-IR (KBr)
νmax:3396,1651,1600,1500,1453 cm
−1;13C NMR (DMSO-d6,
100 MHz) data in Table 1; HRESIMS m/z 676.7400
[M + H]+(calcd for C33 H41 O15, 677.2396).
Phosphorylated icariin (2): yellow amorphous powder;
FT-IR(KBr) νmax:3384,1652,1610,1430,1504,1148,919 cm
−1;
13C NMR (DMSO-d6, 100 MHz) data in Table 1; HRESIMS
m/z 757.2034 [M+H]+(calcd for C33 H42 O18 P, 757.2072).
Animal experiments
Animal experiments conformed to the Guide for the
Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication, Eighth edi-
tion, 2011) and were approved by the Nanjing Agricultural
University Animal Care Committee (No. 20130093, 2013).
To ameliorate suffering, animals which were not expected
to survive were humanely euthanized. All steps were
complied with AVMA Guidelines for the Euthanasia of
Animals (2013 Edition).
One-day-old cherry valley ducks were purchased from
Nanjing Tangquan Poultry Farm (Nanjing, China). Ducks
were housed in wire cages (60 cm× 100 cm) in air condi-
tioned rooms at 37 °C with lights on for 24 h before the
study. The temperature was gradually reduced to room
temperature and 12-h light/12-h dark phases, which were
kept constant for the remainder of the study. Ducks were
fed a commercial starter diet provided by the feed factory of
Jiangsu Academy of Agricultural Science (Nanjing, China).
Three-day-old cherry valley ducks (n = 180) were randomly
divided into four groups: 1-treated group, 2-treated group,
virus control (VC) group, and a blank control (BC) group
(separately reared). Ducklings allocated to the 1, 2 and VC
groups were intramuscularly injected with 0.2 mL of DHAV
(20 × LD50) per duckling. Ducklings allocated to the 1 or 2
groups were given aqueous 1 or 2 at the dosage of
31.25 mg/Kg (net concentration) of per duckling, SID,
for 3 days starting on the same day as DHAV injection.
Before used, 1 was prepared with 3 % ethanol dissolved,
and added a co-solvent 0.5 % Tween 80. In order to en-
sure the consistency of test, we added the equal amount
of ethanol and Tween 80 in the drinking in the 2, VC
and BC groups. The dissolution characteristic of 2 is in-
stant into the water. Blood samples were taken from
five ducklings in each group at the 4thh, the 8thh, and
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the 54thh after injecting DHAV. Half of each blood sample
was treated with heparin for anticoagulation and the
remainder was left to coagulate. Number of ducks which
had been taken blood samples needed to eliminate (n = 15
per group).
Preparation of duck embryonic hepatocytes (DEHs) and
DHAV
Livers were removed from 14-to-16-day-old duck embryos
in sterile conditions followed by gallbladder evisceration
[14]. The livers were washed three times with D-Hank’s.
The tissue was minced with eye scissors and washed three
times with D-Hank’s. Liver tissue was digested with a solu-
tion of 0.2 % trypsin at 37 °C for 4 to 6 min. As soon as
the trypsin was completely absorbed, the tissue was rinsed
three times with D-Hank’s and an appropriate amount of
DMEM growth medium was added. The seeding cell dens-
ity was controlled within the range of 0.8 × 106-1.2 × 106
cell/mL, incubated at 37 °C in a humid atmosphere of 5 %
CO2, the growth medium replaced after 24 h [15]. DMEM
was removed when the duck embryo hepatocytes grew into
monolayer. The duck embryonic hepatocytes monolayer
(DEHs) was washed with calcium and magnesium-free
phosphate-buffered saline (CMF-PBS, pH 7.4) once, and
left as standby until CMF-PBS was removed again. The
DHAV used for challenge experiments and antiviral assays
was supplied by the Shandong Institute of Poultry in China
and proliferated by inoculating DEHs. The TCID50 of the
virus liquid was 1 × 10−3 by Reed-Muench assay [16]. It was
diluted into 5 × 10−2(50 TCID50) with MM and used for
antiviral assays.
Antiviral activity in vitro
The maximum safe concentration of 1 was 250 μg/mL
tested by preliminary experiment with MTT method while
that of 2 was 1250 μg/mL. 1 was serially twofold diluted
with MM from 250 μg/mL to 31.25 μg/mL, and 2 from
1250 μg/mL to 156.25 μg/mL, thus obtaining 4 concentra-
tions each. 70 μL DHAV was added to each well of 96-well
culture plate containing the DEHs monolayer. Meanwhile,
cell control (CC) group and virus control (VC) group were
set. The plate was cultured at 37 °C in a humid atmos-
phere of 5 % CO2 for 2 h. The virus solution was removed
and the monolayer was washed three times with D-
Hank’s. Subsequently, 70 μL dilution of test ingredient
was added to test well using 5 wells per concentration.
The plate was left at 37 °C in a humid atmosphere of 5 %
CO2. As the VC group showed significantly cytopathic
effect (approximately after 72 h), the MTT method was
used to determine the DEHs activity [17]. The A570 value
and virus inhibitory rate [(Ādrug+virus −Āvirus control)/(Ācell
control −Āvirus control) × 100 %] were considered as the indi-
cators of antiviral activity in vitro [18].
Quantitative analysis of blood DHAV
To monitor the blood virus contents in virusemia phases
(the 4thh and the 8thh) and stable (the 54thh) phases of
the disease, blood samples randomly taken from 5
feathers per group at the 4thh, the 8thh and the 54thh
after challenged with virus were collected, treated with
heparin anticoagulation and used for testing its virus
nucleic acid contents. Real-time polymerase chain reac-
tion (Real-time PCR) was employed in the quantitative
analysis of DHAV gene expression at the 4thh, the 8thh
and the 54thh in vivo [19].
Clinical effect
Mortality was calculated after all the young ducklings
ceased to die using the equation: Mortality of each group
(%) = Death in each group/effective samples in each
group × 100 %, and the number of ducks providing blood
samples needed to be eliminated (15 feathers per group).
Analysis of virus replication
400 μL DHAV was added into the 24-well culture plate
containing a DEHs monolayer, while the CC and VC
wells were reserved. The plate was incubated at 37 °C
for 2 h in a humid atmosphere of 5 % CO2, and the virus
solution removed. The plate was washed 3 times with
D-Hank’s. Later, 400 μL dilution of test drug was added
into the test wells, three wells in parallel, as the most ef-
fective antiviral concentration. The 24-well culture plate
was incubated at 37 °C for 24 h in a humid atmosphere
of 5 % CO2 and the total RNA was extracted. Real-time
PCR was used to analyze the extent of virus replication.
Analysis of virus release
400 μL DHAV was added into the 24-well culture plate
containing monolayer DEHS, while the CC and VC wells
were reserved. The plate was incubated at 37 °C for 2 h
in a humid atmosphere of 5 % CO2. The virus solution
was removed and the plate was washed 3 times with
D-Hank’s. 400 μL dilution of test drug at the most ef-
fective antiviral concentration was then added into the
test wells, three wells in parallel. The plate was continu-
ously incubated at 37 °C in a humid atmosphere of 5 %
CO2 for 48 h. The supernatant of cells was centrifuged
and the sediment was removed. 100 μL supernatant and
100 μL DEHs (0.8 × 106-1.2 × 106 cells/mL, as the in-
ternal reference) were mixed together and the total RNA
was extracted. Finally real-time PCR was used to analyze
the virus release content.
Primer design
The primers based on the complete genome of DHAV
(ZJ strain; Genbank: EU841005) were designed using Pri-
mer Premier Software (version 5.0). The forward and re-
verse primers were 5′-GCCACCCTTCCTGAGTTTGT-3′
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(positions: 3336–3355) and 5′-TACCATTCCACTTCTCC
TGCTT-3′ (positions: 3489–3510), respectively. Duck Beta-
actin was selected as the control. The primers based on the
complete coding sequence of Anasplatyrhynchos beta-actin
mRNA (Genbank: EF667345) were designed using Primer
Software (version 5.0). The forward and reverse primers
were 5′-CTTTCTTGGGTATGGAGTCCTG-3′ (positions:
826–847) and 5′-TGATTTTCATCGTGCTGGGT-3′ (po-
sitions: 995–1014), respectively.
Statistical analysis
2-ΔΔCT method was used to analyze relative gene expression
data [20]. The data of A570 value and relative gene expres-
sion value were expressed as the mean ± S.D.. Duncan’s
multiple range tests were used to analyze the difference
among groups with the software SPSS 20.0. χ2-test was
used to analyze the difference between the mortality. Sig-
nificant differences were considered as p < 0.05.
Results
Compound 1 was obtained as a yellow, amorphous pow-
der. Its molecular formula (C33H40O15) was established
on the basis of high-resolution electrospray ionization
mass spectrometry (HRESIMS) (m/z 676.7400 [M +H]+;
calcd for C33H41O15, 677.2396, Fig. 2) in combination
with 13C nuclearmagnetic resonance (NMR) data (Table 1).
The FT-IR spectrum exhibited characteristic absorptions
for hydroxy (3396 cm−1), carbonyl (1651 cm−1), and aro-
matic (1600 and 1454 cm−1) functionalities. It was consist-
ent with the structure of icariin [21].
Compound 2 was obtained as a yellow, amorphous
powder. Its molecular formula (C33H42O18 P) was estab-
lished on the basis of 13C NMR and HRESIMS data (m/z
757.2034 [M+H]+; calcd for C33H42O18P, 757.2072, Fig. 2).
The FT-IR spectrum exhibited characteristic absorptions
for hydroxy (3384 cm−1), carbonyl (1652 cm−1), and aro-
matic (1610 and 1430 cm−1) functionalities, it was similar
to 1. Furthermore, 2 also displayed extra absorption peaks
at 1160.61 and 918.15 cm−1, corresponding to the phos-
phate group. The 13C NMR data (Table 1) of 2 were simi-
lar to those of 1, except for the the C-6''' (1 C-6''':δC61.10;
2 C-6''':δC70.17), it suggested that the phosphate group
was located at C-6''', which instead of oxhydryl. Combined
with FT-IR, HRESIMS and 13C NMR data, suggesting that
compound 2 was also a phosphorylated derivative of 1
and the structure was defined as 8-prenylkaempferol-4′-
methylether-3-rhamnosyl-7- (6'''-phosphate)-glycoside and
given the name 6'''-phosphate icariin.
Table 2 listed the A570 values and virus inhibitory rate
in the anti-DHAV activity test in DEHs. The A570 values
of the 1 group ranging from 62.5 μg/mL to 31.25 μg/
mL, and the A570 values of the 2 group ranging from
312.5 μg/mL to 156.25 μg/mL were significantly higher
than that of the VC group. The A570 value of the 2 at
156.25 μg/mL was also notably higher than that of the
CC group, which indicated that 2 also promote cell
growth. The virus inhibitory rates of 2 were higher than
that of 1 at similar concentrations, with the highest one
at 135.78 %, while the highest of 1 being 98.28 %.
The mortality of young ducklings in the BC, VC, 1, 2
groups was 0,30,24,21 feathers. All ducklings in the BC
group survived. After treatment with 1 and 2, the young
ducklings challenged with DHAV no longer died after
72 h, while all of the ducklings in the VC group died on
the 4th day. Both mortality of compound 1 (80 %) and
compound 2 (70 %) were lower than that of the VC
group (100%), and compound 2 group’s mortality was
significantly lower than that of the VC group.
A quantitative analysis of the DHAV gene expression
in blood at the 4th, the 8th and the 54th h after injected
with virus was illustrated in Fig. 3. No DHAV gene
expression was found in the BC group. DHAV gene ex-
pression of the VC group in the 4th h after injected virus
was set to 1 and that of the BC group was set to 0. The
VC group dynamics indicated that the DHAV content
first increased and then decreased in vivo of ducklings,
with the pattern of the 1 and 2 groups similar to that of
the VC group. The relative expressions of DHAV gene in
blood of the 1 and 2 groups were lower than that of the
VC group during the same period. Four hours after
DHAV injection, the virus gene expressions in both the
1 and 2 groups were lower than that of the VC group.
At the 8th hour after DHAV injection the virus contents
of the 1 and 2 groups were lower than that of the VC
group with significant difference. At the 54th h after
DHAV injection the virus gene content of the 2 group
was remarkably lower than that of the VC group.
The effect of 1 and 2 on replication of DHAV was il-
lustrated in Fig. 4. No DHAV gene expression was found
in the CC group. DHAV gene expression of the VC
group in the twenty-fourth hour was set to 1. Relative
DHAV gene expressions of 1 and 2 groups were 0.549
and 0.248; both were significantly lower than that of the
VC group. Relative expression of 2 was significantly
lower than that of 1.
The effect of 1 and 2 on the release of DHAV was
illustrated in Fig. 5. No DHAV gene expression was
found in the CC group. The DHAV gene expression of
the VC group in the 48 h was set to 1 and that of the
BC group was set to 0. Relative expressions of 1 and 2
were 0.476 and 0.575. And both were significantly lower
than that of the VC group.
Discussion
Acid ions cannot only bind to virus or cell skin cation
to inhibit viral invasion or replication, but also enhance
the antiviral effect and water solubility of drugs [22].
This experiment sought for the optimal conditions for
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phosphorylated modification of 1 and successfully in-
troduced phosphate group. It still preserved the fla-
vones’ basic chemical structure. The results showed
that 2 had significantly better water solubility than 1
and was suitable for practical application. The higher
the drug’s maximum concentration was, the safer it was
inside the cell in vitro [23]. In the present experiment,
the maximum tolerable dose of 2 (1250 μg/mL) was
much higher than that of 1 (250 μg/mL). The results
indicated that the cellular toxicity of 1 may be signifi-
cantly reduced by phosphorylation.
The antiviral activity assays of 1 and 2 in vitro using
MTT method indicated that higher A570 values were as-
sociated with improved antiviral properties [24]. Virus
inhibitory rates directly reflected the drug’s antiviral per-
formance. Within a certain range, the A570 values of 1
and 2 were significantly higher than that of the VC
group; with some A570 values of 2 even higher than the
Table 2 A570 values and virus inhibitory rate in DHAV test on DEHs
Group ConcentrationA (μg/mL) A570 Virus inhibitory rate(%) Group ConcentrationA (μg/mL) A570 Virus inhibitory rate(%)
1 250 0.191 ± 0.026c 1.72 2 1250 0.241 ± 0.026c 0.92
125 0.211 ± 0.032bc 18.97 625 0.261 ± 0.010c 19.27
62.5 0.230 ± 0.016b 35.34 312.5 0.365 ± 0.032ab 114.68
31.25 0.303 ± 0.013a 98.28 156.25 0.388 ± 0.020a 135.78
VC 0.189 ± 0.018c VC 0.240 ± 0.014c
CC 0.305 ± 0.006a CC 0.349 ± 0.024b
Data within a column without the same superscripts (a–c) differ significantly (p < 0.05)
ab With a and b were no significant differences. bc With b and c were no significant differences
A The safe concentration determined by prior cytotoxicity tests
Fig. 2 HRESIMS spectrum of compound 1 and 2
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CC group. Within the effective concentration range,
the virus inhibitory rates of 2 and the maximum inhibi-
tory rate were both higher than those of 1. The results
suggested that both 2 and 1 in vitro possessed strong
anti-DHAV function, with 2 stronger than 1.
In clinical trials, DHAV was infectious for young duck-
lings aged up to 3 weeks, particularly those less than 1-
week-old, whose mortality rate was higher than 90 %
[25]. Therefore, we selected 3-day-old young ducklings
for this experiment taking into account the clinical
significance. In this study, all ducklings in the BC
group survived. After treatment with 1 and 2, the
young ducklings challenged with DHAV no longer
died after 72 h, while all of the ducklings in the VC
group died on the 4th day. Mortalities of the 1 and 2
groups were both lower than that of the VC group,
which proved that both 1 and 2 had anti-DHV effect.
If focused on the mortality of the 2 group, we could
Fig. 3 Quantitative analysis of the DHAV gene expression in blood at the 4th, the 8th and the 54th h after injected virus. DHAV gene expression of the
VC group at 4 h after injected virus was set to 1 and that of the BC group was set to 0. The different letters on a column differ significantly (p < 0.05)
Fig. 4 Replication DHAV gene expression in DEHs. Effect of 1 and 2 on DHAV replication. DHAV gene expression of the VC group was set to 1 and that
of the BC group was set to 0. The different letters on a column differ significantly (p < 0.05)
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find that it was significantly lower than that of the VC
group, indicating its superior effect compared to 1.
The results were consistent with the anti-DHAV in-
vading cells, in vitro.
DHAV is classified in the family parvoviridae [26]. It
completes a cycle of replication in 6–8 h, in vivo. In
early phase of infection, humoral immunity to anti-
DHAV is still not active. Instead, organisms mainly re-
lied on the direct antivirus effects of the drug. A quanti-
tative analysis of the DHAV gene expression in blood at
the 4th, the 8th and the 54thh after injected with virus
was illustrated in Fig. 3. Four hours after virus invasion,
it was possible that virus still failed to complete replica-
tion. As the gene expressions of DHAV in the 1 and 2
groups were lower than that of VC group, no substantial
differences between virus level in blood of the 1, 2 and
VC groups was observed. At the 8thh, the virus had at
least completed one replication cycle. The blood virus
contents in the 1 and 2 groups were significantly lower
than that of the VC group. In addition, since 2 was more
potent, the 2 group blood virus content was lower than
that of the 1 group. At the 54thh, with the activation of
humoral immunity and increased cytokine levels, the
levels of the 1, 2 and VC groups’ blood virus plum-
meted. The 1 and 2 groups’ blood virus contents were
lower than that of the VC group and this is especially
significant for the 2 group. The results were consistent
with the death of the ducklings in the challenging ex-
periment. We are submitting another article has re-
ported that the contents of IFN-γ, IL-2 and IL-6 in the 1
and 2 groups were significantly higher than those in the
VC group at the 54thh, which indicated that 1 and 2
could obviously improve immunomodulatory activity. It
also demonstrated that the treatment of traditional
Chinese medicine maybe more reflected in the balance
of the internal systems, rather than directly inhibited or
killed pathogenic microorganisms.
Previous studies established a solid basis for the mo-
lecular detection of DHAV using Real-time PCR [19].
RT-PCR with its higher specificity, less PCR contamin-
ation and higher automation has been widely applied in
the field of diagnosis and detection of DHAV. During
virus replication, the relative quantitative gene expres-
sions of the 1 and 2 groups were significantly lower than
that of the VC group (Fig. 4). The results suggested that 1
and 2 greatly inhibited the replication of DEHs in vitro,
and that 2 outperformed 1. Lu et al. [22] also found that
acid ions prevented virus from replicating inside cells.
Acid ions of PO4
3− introduced into 1 enhanced the inhib-
ition of DHAV in vitro.
In virus release phase (Fig. 5), the relative quantitative
gene expressions of the 1 and 2 groups were significantly
lower than that of the VC group. Both had similar in-
hibitory effect on DHAV releasing DEHs in vitro. There-
fore, based on the results of virus replication and release
in vitro, both 1 and 2 had significant inhibitory function
on virus activity, although the 2 was better due to its
acidic groups. Due to direct inhibition of virus replica-
tion in the 1 and 2 groups, and consequent lowered
blood viral content, the ducks were spared from possible
harm and showed a decreased Mortality, especially true
for the 2 group. The antiviral immune response stimu-
lated by the 1 and 2 also helped in substantially reducing
the damage due to DHAV. Additional studies to confirm
our findings in vivo are required.
Supporting information
13C NMR of compound 1and compound 2.
Fig. 5 Release DHAV gene expression in DEHs. Effect of 1 and 2 on DHAV release. DHAV gene expression of the VC group was set to 1 and that
of the BC group was set to 0. The different letters on a column differ significantly (p < 0.05)
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Conclusion
The compound 2 was also a phosphorylated derivative
of 1 and the structure was defined by FT-IR, HRESIMS
and 13C NMR. Compound 1 and 2 effectively resisted
DHAV from invading DEHs in vitro , and had good
therapeutic effects in young ducklings infected with
DHAV. The Mortality was significantly decreased and 2
showed better effect than 1, it showed that the novel
structure was worth further research for application.
The mechanism underlying the antiviral activity of 2 and
1 in vitro was probably mediated by interference with
the replication and release of virus. Due to the greater
inhibition on virus replication than 1, 2 showed better
antiviral effect.
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